Ulcerative Colitis

Patients suffering from irritable bowel syndrome with constipation (IBS-C) may benefit from a new drug, plecanatide, making its way through the approval pipeline.

Researchers from the University of North Carolina examined the gene expression and regulation in colon tissue from patients to better understand the cellular and molecular mechanisms that make up Crohn’s disease.

Alternative therapies such as probiotics and synbiotics may be viable options for patients with irritable bowel disorders, according to findings published in the British Journal of Pharmacology.

A new study out of Ireland examined the prevalence of extra-articular manifestations in axial spondyloarthritis, and found that women were at significantly higher risk for inflammatory bowel disease and uveitis than men.

Patients experiencing pain from irritable bowel syndrome (IBS) might find relief from an unlikely source.

The FDA has granted approval for ustekinumab (Stelara/Janssen Biotech) to treat adults with moderately-to severely active Crohn’s disease (CD).

Crohn’s disease can impact brain function in the capacities of slower response times than individuals without Crohn’s, according to findings published in UEG Journal.

Even a severe medical condition won’t let players avoid the NFL’s recent seemingly admirable stance on substance abuse violations.

To help physicians effectively manage septic perianal Crohn’s disease (CD), Penn State College of Medicine researchers published a medical and surgical care plan based on a decade’s worth of analyses and patient outcomes.

Ginger ale has long been considered a non-medicinal option for soothing upset stomachs. Didier Merlin, MD, and colleagues from the Atlanta VA medical Center and Institute for Biomedical Sciences at Georgia State University, have taken this concept a step further, exploring the use of edible ginger-derived nanoparticles (GDNPs) to treat inflammatory bowel disease.

MD Magazine spoke with world-renowned soccer star, Brandi Chastain, who recently partnered with AbbVie on a new advocacy campaign, My IBD Game Plan, in the wake of her son’s Crohn’s disease diagnosis. Millie Long, MD, MPH, shared the clinical landscape and management methods for the condition.

In addition to battling gastrointestinal conditions, patients suffering from ulcerative colitis (UC) also often have to deal with poor oral health.

Patients afflicted with ulcerative colitis (UC) that practiced hatha yoga – a practice of physical yoga postures – for a 12-week period noticed a significant decline in their disease activity.

A new study found that female psoriasis patients have a fourfold increased risk of developing Crohn’s disease (CD).

Inflammatory bowel disease (IBD) incidence peaks during a woman’s reproductive years.

In patients diagnosed with psoriasis, disease severity has been strongly associated with developing a higher risk of comorbidities affecting the kidney, liver, and pancreas.

Most patients are well-meaning and generally nice. But every now and then, you will get one who is a total pain to deal with. Maybe your patient lies to you, gets sarcastic, asks for special “favors,†or generally just pushes your buttons. We’ve all been there.

It is frustrating, to say the least, when your patients take their frustrations out on you. And, as if having to deal with an angry patient isn’t bad enough, providers now have to worry about the threat of legal action more than ever before.

When intestinal stem cells come into contact with prominent metabolites in the gut, the intestine is prohibited from repairing itself with those cells, according to findings published in Cell.

The Remicade biosimilar inflectra (infliximab) appeared safe and effective for the treatment of Crohn’s disease (CD) and ulcerative colitis (UC) across 38 weeks, according to a presentation at Digestive Disease Week 2016.

Tonsillectomies have typically been considered to be one of the surgical procedures younger patients often irrationally fear.

Good gut bacteria function is inhibited in Crohn’s disease (CD) patients by genetic variations, which can cause inflammatory flare-ups, according to findings published in the journal Science.

A Liverpool, England teen’s viral Facebook post shed light on what it’s like to live with Crohn’s disease (CD) and an ileostomy bag, or stoma bag.

Arachnophobes suffering from irritable bowel syndrome (IBS) may have to put their fear on hold to welcome pain relief from their gastrointestinal condition.

Patients dealing with anxiety or depression often also suffer from recurring inflammatory bowel disease (IBD), a recent study found.

It is widely known that fecal microbiota transplantation (FMT) is effective for the treatment of recurring Clostridium difficile (C. diff) infection, but new research supports the procedure’s efficacy for helping patients with ulcerative colitis (UC).

Biomarkers are able to predict inflammatory bowel disease (IBD) development and complications, according to findings published in the journal Alimentary Pharmacology and Therapeutics.

Filgotinib is the first oral, JAK1-selective inhibitor showing efficacy in moderate-to-severe Crohn's disease patients.

Risankizumab is a humanized monoclonal antibody that selectively inhibits IL-23 through specific targeting of the IL-23 p19 subunit.

Mothers’ inflammatory bowel disease (IBD) therapies may impact their newborns, according to findings published in Gastroenterology.